In another recent study on a murine model of non-Hodgkin's lymphoma, PD-1 signaling prevented cancerous T-cell proliferation, i.e., PD-1 blockade would actually reactivate cancerous T-cells to promote their replication and hence accelerate malignant growth (36). Here, PDCD1 is linked to non-Hodgkin lymphoma.